Compare Amphastar Pharmaceuticals Inc (AMPH) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

TSLL is trading at $13.09, up 0.54% with a bearish technical signal from moving averages. Key support levels are at $12 and $11, while resistance sits at $13 and $14. The stock shows neutral oscillator readings with RSI levels around 46-50, indicating balanced momentum. Recent news highlights interest in derivative-based ETF strategies and connections to Tesla's performance.

The outlook remains cautious due to bearish technical indicators and limited fundamental data availability. Investment opportunities may exist for those speculating on Tesla-related volatility through this ETF, but risks include market volatility and dependency on underlying asset performance. The neutral sentiment from oscillators suggests waiting for clearer directional signals.